Skip to main content
. 2023 Jan 22;15(2):382. doi: 10.3390/pharmaceutics15020382

Figure 13.

Figure 13

The XRD diffractograms: (a) curcumin, (b) 2-hydroxypropyl-β-cyclodextrin, (c) inclusion complex of curcumin: 2-hydroxypropyl-β-cyclodextrin, (d) p(NiPMAm/NiPAm) hydrogel containing 2 mol% of crosslinker, and (e) p(NiPMAm/NiPAm) hydrogel with incorporated curcumin: 2-hydroxypropyl-β-cyclodextrin complex.